−80 KRW
−1.87 B KRW
29.90 B KRW
17.26 M
About L&K BIOMED CO., LTD.
Sector
Industry
Headquarters
Yongin-si
Website
Founded
2008
ISIN
KR7156100000
FIGI
BBG004RKXVG5
L&K BIOMED Co., Ltd. engages in the manufacture and sale of implants for vertebra. Its products include spinal fixation devices and spinal surgery products used in orthopedics and neurosurgery. The company was founded on December 22, 2008 and is headquartered in Yongin-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 156100 is 6,800 KRW — it has increased by 1.64% in the past 24 hours. Watch L&K BIOMED CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange L&K BIOMED CO., LTD. stocks are traded under the ticker 156100.
156100 stock has fallen by −2.86% compared to the previous week, the month change is a −1.45% fall, over the last year L&K BIOMED CO., LTD. has showed a −29.90% decrease.
156100 reached its all-time high on Jan 11, 2021 with the price of 56,280 KRW, and its all-time low was 3,590 KRW and was reached on May 15, 2020. View more price dynamics on 156100 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
156100 stock is 2.39% volatile and has beta coefficient of 0.54. Track L&K BIOMED CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is L&K BIOMED CO., LTD. there?
Today L&K BIOMED CO., LTD. has the market capitalization of 133.38 B, it has increased by 5.42% over the last week.
Yes, you can track L&K BIOMED CO., LTD. financials in yearly and quarterly reports right on TradingView.
156100 net income for the last quarter is −1.13 B KRW, while the quarter before that showed 993.14 M KRW of net income which accounts for −213.44% change. Track more L&K BIOMED CO., LTD. financial stats to get the full picture.
No, 156100 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 60.00 employees. See our rating of the largest employees — is L&K BIOMED CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. L&K BIOMED CO., LTD. EBITDA is 5.41 B KRW, and current EBITDA margin is 14.54%. See more stats in L&K BIOMED CO., LTD. financial statements.
Like other stocks, 156100 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade L&K BIOMED CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So L&K BIOMED CO., LTD. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating L&K BIOMED CO., LTD. stock shows the sell signal. See more of L&K BIOMED CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.